Author | Thomas W. Dubensky, PhD | OncLive

Author | Thomas W. Dubensky, PhD

Articles

Thomas Dubensky on How ADU-S100 Activates STING

April 29, 2016

Video

Thomas W. Dubensky Jr, PhD, chief scientific officer, Aduro Biotech, discusses a study of ADU-S100 and how it activates the human STING receptor, which is found to have presence in multiple tumor types.

x